ADDvise receives order worth USD 1.2 million
ADDvise Group AB’s subsidiary Poly Pharmaceuticals Inc has received an additional order from Cochran Wholesale Pharmaceuticals, a generic pharmaceutical wholesale distributor serving the needs of independent pharmacies across the USA. The order is worth approximately USD 1.2 million. The order consists of delivery of the dietary supplemental Folite, developed and manufactured by Poly Pharmaceuticals. Delivery will take place during Q4 2022. “We see a strong demand in the US market for generic drugs. Generic drugs are a low-cost alternative to branded drugs. Macroeconomic headwinds are